We previously reported that unsaturated fatty acids stimulated low-density lipoprotein (LDL)particle uptake in J774 macroph
ages by increasing LDL receptor activity. Since free fatty acids (FFA)also change plasma membrane properties, a putative cholesteryl ester (CE) acceptor for selective uptake(SU), we questioned the ability of FFA to modulate SU from LDL. Using [
3H]cholesteryl ether/
125I-LDLto trace CE core and whole particle uptake, we found that oleic acid and eicosapentaenoic acid, but notsaturated stearic acid, increased SU by 30% over control levels. An ACAT inhibitor, Dup128, abolishedFFA effects on SU, indicating that increased SU by FFA was secondary to changes in cell-free cholesterol(FC). Consistent with these observations, ACAT inhibition increased cell FC and reduced LDL SU byhalf. The important role of plasma membrane composition was further demonstrated in that
![](/im<font color=)
ages/gifchars/beta2.gif" BORDER=0 ALIGN="middle">-cyclodextrin-(
![](/im<font color=)
ages/gifchars/beta2.gif" BORDER=0 ALIGN="middle">-CD-) mediated FC removal from the plasma membrane increased SU from LDL and was furtherstimulated by U18666A, a compound that inhibits FC transport between lysosomes and the plasmamembrane. In contrast, cholesterol-saturated
![](/im<font color=)
ages/gifchars/beta2.gif" BORDER=0 ALIGN="middle">-CD markedly reduced LDL SU. In contrast to LDL SU,oleic acid, ACAT inhibition, U18666A, or
![](/im<font color=)
ages/gifchars/beta2.gif" BORDER=0 ALIGN="middle">-CD had no effects on HDL SU. Moreover, HDL SU wasinhibited by antimouse SR-BI antibody by more than 50% but had
little effect on LDL SU. In C57BL/6m
ice fed a high fat diet, plasma FFA levels increased, and SU accounted for an almost 4-fold increasedproportion of total cholesterol delivery to the arterial wall. Taken together, these data suggest that LDLSU is mediated by pathways independent of SR-BI and is influenced by plasma membrane FC content.Moreover, in conditions where elevated plasma FFA occur, SU from LDL can be an important mechanismfor cholesterol delivery in vivo.